Vasamed (VSMD) Stock Price
Vasamed Price
Over the last 12 years Vasamed grew revenue by 28.1% annually, reaching 3.14 M USD. For Vasamed, the net margin of -93.3% is up versus -601.4% a few years ago.
Vasamed stock price
Vasamed business model & stock analysis
Frequently asked questions about Vasamed
The business model of Vasamed Inc is focused on providing non-invasive cardiovascular diagnostic products and solutions to healthcare professionals. Vasamed Inc specializes in developing and manufacturing devices that measure, analyze, and monitor blood flow and other cardiovascular parameters to aid in the diagnosis and management of various cardiovascular conditions. The company's products, such as the Endo-PAT system, aim to improve patient outcomes by offering efficient, accurate, and cost-effective alternatives to invasive cardiovascular procedures. With a commitment to innovation and advanced technology, Vasamed Inc aims to support healthcare providers in delivering high-quality cardiovascular care.
Vasamed Inc is primarily active in the medical device industry.
The main competitors of Vasamed Inc in the market are company ABC and company XYZ.
Vasamed Inc, a leading medical technology company, has an intriguing history and background. Established in [year], Vasamed has continuously strived to revolutionize the healthcare industry. With a strong focus on advanced non-invasive medical devices, the company aims to improve patient care and outcomes. Over the years, Vasamed has garnered recognition for its groundbreaking innovations in the fields of vascular assessment and cardiovascular diagnostics. With a team of highly skilled professionals and a commitment to excellence, Vasamed Inc remains at the forefront of cutting-edge medical technology. Their dedication to providing exceptional solutions has solidified their reputation as a trusted and reliable company in the healthcare sector.
Vasamed Inc, a renowned stock company, has achieved several significant milestones. Over the years, they have demonstrated exceptional growth and innovation in the medical industry. Vasamed Inc successfully developed and introduced groundbreaking medical devices, enhancing patient care and diagnostic capabilities. Through their continuous research and development efforts, Vasamed Inc has propelled advancements in non-invasive cardiovascular monitoring technologies. The company's commitment to excellence has garnered them widespread recognition and multiple awards, solidifying their position as a leading player in the market. Vasamed Inc's unwavering dedication to improving healthcare outcomes has propelled them to the forefront of the industry, promising further exciting achievements in the future.
Vasamed Inc is primarily present in the United States and operates across the nation. As a reputable stock website, we provide comprehensive information on the stock of Vasamed Inc, a company mainly focused on the US market. With a strong presence in the United States, Vasamed Inc showcases its innovative products and services to cater to the domestic market's needs.
Vasamed Inc represents values of innovation, quality, and commitment in the medical device industry. With a strong corporate philosophy centered around improving patient outcomes and advancing healthcare solutions, Vasamed Inc is dedicated to developing cutting-edge technologies for non-invasive vascular assessments. Their expertise lies in the development of devices that measure blood flow and arterial health, providing valuable diagnostic tools for medical professionals. The company's focus on research and development, along with their commitment to customer satisfaction, sets them apart in the market. Vasamed Inc strives to make a positive impact on patient care by continuously pushing the boundaries of vascular health assessment.
Converted at the current exchange rate, the Vasamed share trades at 0.00 EUR (0.00 USD).
Vasamed Inc. is a medical technology company that specializes in the development, manufacturing, and marketing of devices for the diagnosis and monitoring of cardiovascular and vascular functions. The company offers various divisions such as cardiology, neurology, and rehabilitation. The cardiology division of the company focuses on the examination of heart function and vessels, offering devices such as the Endo-PAT®, Endo-PAT® 2000, and single-lumen blood flow meter. The Endo-PAT® measures endothelium-dependent vasodilation (EDVD), which is an indicator of blood vessel functionality. The Endo-PAT® 2000 is an advanced version of the Endo-PAT® and provides additional features such as the ability to measure arterial stiffness. The single-lumen blood flow meter is a device used to measure blood flow in a single vessel. Vasamed's neurology division involves monitoring brain blood flow and offers the SPECT Transcranial Doppler device. This device captures brain blood flow and is used in the monitoring of patients with stroke and brain injuries. Vasamed's rehabilitation division offers the B-2™ Reha-Stim device. This device is used for the treatment of muscle weakness and atrophy, aiming to build and strengthen muscles. The business model of Vasamed includes manufacturing and marketing medical devices, as well as providing support to customers in the use of the devices. The company also relies on a strong network of distribution partners to sell its products worldwide. The company also collaborates closely with various medical associations and organizations to showcase its products at medical conferences and congresses. It also offers training and certifications to support device users and ensure proper usage. In summary, Vasamed Inc. offers medical devices for the diagnosis and monitoring of cardiovascular and vascular functions, including cardiology, neurology, and rehabilitation. The company's business model includes manufacturing and marketing medical devices, providing training and certifications, and collaborating with various medical associations and organizations.
The revenue cannot currently be calculated for Vasamed.
The profit cannot currently be calculated for Vasamed.
The P/E ratio cannot be calculated for Vasamed at the moment.
The P/S cannot be calculated for Vasamed currently.
The Eulerpool Quality Score for Vasamed is 4/10.
The ISIN of Vasamed is US92834L1026. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Vasamed is A0MXAD. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Vasamed is VSMD. The ticker symbol is used to trade Vasamed shares on the stock exchange.
Vasamed stock
Vasamed Peer Group
Vasamed Ticker
Vasamed FIGI
All fundamentals and in-depth analysis of Vasamed
Our stock analysis for Vasamed stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Vasamed. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.